Eikon Therapeutics, Inc. EIKN
$9.02
▲ +2.70% 24H
About
Eikon Therapeutics, Inc. is a late-stage clinical biopharmaceutical company pioneering advanced drug discovery through visualization of protein motion in living cells. Founded in 2019 and headquartered in Millbrae, California, it employs 384 people and focuses on developing therapies primarily for cancer treatment usin…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees384
TickerEIKN
Statistics
Market Cap$488.1M
Revenue (TTM)—
Net Income—
Net Margin—
EPS$-6.32
P/E-1.37
P/S—
P/B0.86
EV/EBITDA-0.70
ROE38.0%
Dividend Yield—
Price$9.02
Data: Twelve Data · Revenue = mcap / P/S